BIIB and REGN Related Headlines
Go Back- U.S. Biotech stocks: Q1 earnings previews
- RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
- 4Q25/2026 Biotech Earnings Preview: RBC
- Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'
- Biotech stocks dip as Trump administration mulls patent fee overhaul
- These 30 global stocks offer tactical and structural upside, says RBC
